Annual ROE
-59.03%
-21.03%-55.34%
December 31, 2023
Summary
- As of February 8, 2025, IMRX annual return on equity is -59.03%, with the most recent change of -21.03% (-55.34%) on December 31, 2023.
- During the last 3 years, IMRX annual ROE has fallen by -134.83% (-177.88%).
- IMRX annual ROE is now -149.99% below its all-time high of 118.09%, reached on December 31, 2019.
Performance
IMRX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-79.19%
-13.16%-19.93%
September 30, 2024
Summary
- As of February 8, 2025, IMRX quarterly return on equity is -79.19%, with the most recent change of -13.16% (-19.93%) on September 30, 2024.
- Over the past year, IMRX quarterly ROE has dropped by -23.40% (-41.94%).
- IMRX quarterly ROE is now -130.33% below its all-time high of 261.13%, reached on June 30, 2021.
Performance
IMRX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
IMRX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -55.3% | -41.9% |
| 3 y3 years | -177.9% | -108.6% |
| 5 y5 years | -150.0% | -108.6% |
IMRX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -55.3% | at low | -135.3% | at low |
| 5 y | 5-year | -150.0% | at low | -130.3% | +86.0% |
| alltime | all time | -150.0% | at low | -130.3% | +86.0% |
Immuneering ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -79.19%(+19.9%) |
| Jun 2024 | - | -66.03%(+18.4%) |
| Mar 2024 | - | -55.79%(+6.3%) |
| Dec 2023 | -59.03%(+55.3%) | -52.49%(+8.5%) |
| Sep 2023 | - | -48.40%(+3.7%) |
| Jun 2023 | - | -46.67%(+5.5%) |
| Mar 2023 | - | -44.24%(+16.5%) |
| Dec 2022 | -38.00% | -37.96%(+12.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -33.66%(-14.3%) |
| Jun 2022 | - | -39.28%(-11.5%) |
| Mar 2022 | - | -44.40%(-24.2%) |
| Dec 2021 | -50.24%(-166.3%) | -58.59%(-33.3%) |
| Sep 2021 | - | -87.83%(-133.6%) |
| Jun 2021 | - | 261.13%(-146.1%) |
| Mar 2021 | - | -565.83%(-846.5%) |
| Dec 2020 | 75.80%(-35.8%) | 75.80% |
| Dec 2019 | 118.09% | - |
FAQ
- What is Immuneering annual return on equity?
- What is the all time high annual ROE for Immuneering?
- What is Immuneering annual ROE year-on-year change?
- What is Immuneering quarterly return on equity?
- What is the all time high quarterly ROE for Immuneering?
- What is Immuneering quarterly ROE year-on-year change?
What is Immuneering annual return on equity?
The current annual ROE of IMRX is -59.03%
What is the all time high annual ROE for Immuneering?
Immuneering all-time high annual return on equity is 118.09%
What is Immuneering annual ROE year-on-year change?
Over the past year, IMRX annual return on equity has changed by -21.03% (-55.34%)
What is Immuneering quarterly return on equity?
The current quarterly ROE of IMRX is -79.19%
What is the all time high quarterly ROE for Immuneering?
Immuneering all-time high quarterly return on equity is 261.13%
What is Immuneering quarterly ROE year-on-year change?
Over the past year, IMRX quarterly return on equity has changed by -23.40% (-41.94%)